Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,286,837 papers from all fields of science
Search
Sign In
Create Free Account
ApoC-III
Known as:
ApoC III
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Apolipoprotein C-III, human
Broader (1)
apolipoprotein C-III
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance[S]
B. Ramms
,
Sohan Patel
,
+13 authors
P. Gordts
Journal of Lipid Research
2019
Corpus ID: 155101687
Hypertriglyceridemia results from accumulation of triglyceride (TG)-rich lipoproteins (TRLs) in the circulation and is associated…
Expand
2015
2015
Lack of predictive power of plasma lipids or lipoproteins for gestational diabetes mellitus in Japanese women
Y. Iimura
,
M. Matsuura
,
+5 authors
T. Hiyoshi
Journal of Diabetes Investigation
2015
Corpus ID: 2202521
To determine the diagnostic potential of plasma lipids and apolipoproteins in gestational diabetes mellitus (GDM), we carried out…
Expand
2014
2014
Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.
C. Ballantyne
,
H. Bays
,
+5 authors
R. Juliano
Journal of Clinical Lipidology
2014
Corpus ID: 8669811
Highly Cited
2014
Highly Cited
2014
Apolipoprotein C-III is an amyloid-β-binding protein and an early marker for Alzheimer's disease.
Y. Shih
,
K. Tsai
,
+4 authors
Y. Kuo
Journal of Alzheimer's Disease
2014
Corpus ID: 5119414
It has been demonstrated that peripheral injection of anti-amyloid-β (Aβ) antibodies to patients with Alzheimer's disease (AD…
Expand
2013
2013
"Janus" Cyclic Peptides: A New Approach to Amyloid Fibril Inhibition?
N. Todorova
,
L. Yeung
,
A. Hung
,
I. Yarovsky
PLoS ONE
2013
Corpus ID: 16001562
Cyclic peptides are increasingly being shown as powerful inhibitors of fibril formation, and have the potential to be therapeutic…
Expand
2010
2010
Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels
Ruixing Yin
,
Yiyang Li
,
+7 authors
Weixiong Lin
Lipids in Health and Disease
2010
Corpus ID: 10147771
BackgroundBoth apolipoprotein (Apo) C-III gene polymorphism and alcohol consumption have been associated with increased serum…
Expand
2009
2009
Effect of oxidation and mutation on the conformational dynamics and fibril assembly of amyloidogenic peptides derived from apolipoprotein C-II.
F. Legge
,
K. Binger
,
+4 authors
I. Yarovsky
Journal of Physical Chemistry B
2009
Corpus ID: 13265421
The oxidation of methionine residues in proteins can inhibit the self-assembly of proteins to form amyloid fibrils. For human…
Expand
2008
2008
Analysis of 6-month effect of orlistat administration, alone or in combination with fenofibrate, on triglyceride-rich lipoprotein metabolism in overweight and obese patients with metabolic syndrome.
T. Filippatos
,
V. Tsimihodimos
,
+4 authors
M. Elisaf
Journal of Clinical Lipidology
2008
Corpus ID: 6359200
1981
1981
The Degree of Sialylation of ApoC-III Is Altered by Diet
W. Patsch
,
G. Schonfeld
Diabetes
1981
Corpus ID: 5063012
ApoC-III, an apolipoprotein that contains from 0 to 3 or more moles of sialic acid per mole of protein, plays important roles in…
Expand
Highly Cited
1979
Highly Cited
1979
Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II.
A. Catapano
,
P. Kinnunen
,
+5 authors
J. Sparrow
Biochemical and Biophysical Research…
1979
Corpus ID: 8856128
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE